MERS CoV News and Research

RSS
In recent history, we have witnessed the emergence of several different life-threatening viruses. In addition to causing serious public health concerns around the globe, they have been responsible for significant human morbidity and mortality. Modern life that entails uncurtailed travel of humans and goods means that initially localized outbreaks may pose a risk of transmission anywhere in the world.
Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

An increase in the half-life of remdesivir for COVID-19 treatment

An increase in the half-life of remdesivir for COVID-19 treatment

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Importance of cross-neutralizing antibodies against SARS-CoV-2 variants

Importance of cross-neutralizing antibodies against SARS-CoV-2 variants

Toll-like receptor 2 - novel target for improved COVID-19 vaccines

Toll-like receptor 2 - novel target for improved COVID-19 vaccines

Game animals as potential drivers of disease emergence

Game animals as potential drivers of disease emergence

Pregnancy outcomes during the Jordanian COVID-19 national lockdown

Pregnancy outcomes during the Jordanian COVID-19 national lockdown

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Phage-like particle system provides a platform for quick and easy vaccine generation

Phage-like particle system provides a platform for quick and easy vaccine generation

Coronaviruses synthesize RNA in membrane-bound compartments

Coronaviruses synthesize RNA in membrane-bound compartments

Current understanding of the link between COVID-19 and cardiovascular disease

Current understanding of the link between COVID-19 and cardiovascular disease

SARS-CoV-2 infection regulates protein arginylation

SARS-CoV-2 infection regulates protein arginylation

COVID-19 drug candidate with wide-ranging antiviral activity

COVID-19 drug candidate with wide-ranging antiviral activity

Invalidation of potential SARS-CoV-2 protease inhibitors

Invalidation of potential SARS-CoV-2 protease inhibitors

Discovery of potent neutralizing antibodies against SARS-CoV-2 variants

Discovery of potent neutralizing antibodies against SARS-CoV-2 variants

SARS-CoV-2 Nsp1 deletions affect protein stability and translation inhibition

SARS-CoV-2 Nsp1 deletions affect protein stability and translation inhibition

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Cross-reactive immunity against coronaviruses

Cross-reactive immunity against coronaviruses

The ability of natural flavonoids to inhibit SARS-CoV-2

The ability of natural flavonoids to inhibit SARS-CoV-2

How long does natural or vaccine-induced immunity to COVID last?

How long does natural or vaccine-induced immunity to COVID last?